Selective Octahydro-Cyclopenta[c]pyrrole Negative Modulators of NR2B
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- NOVARTIS AG, Basel, Switzerland has been assigned a patent (No. US 12161624 B2, initially filed Aug. 10, 2021) developed by three inventors David R. Anderson, Salem, Connecticut; Robert A. Volkmann, Mystic, Connecticut; and Frank S. Menniti, Mystic, Connecticut, for "Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B." . . .